"10.1371_journal.pone.0079914","plos one","2013-11-08T00:00:00Z","Shin-Ichiro Miura; Naoki Nakao; Hiroyuki Hanzawa; Yoshino Matsuo; Keijiro Saku; Sadashiva S Karnik","Department of Cardiology, Fukuoka University School of Medicine, Fukuoka City, Fukuoka, Japan; Department of Molecular Cardiovascular Therapeutics, Fukuoka University School of Medicine, Fukuoka City, Fukuoka, Japan; Department of Molecular Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio, United States of America; R&D Division, Daiichi Sankyo Company, Ltd., Tokyo, Japan","Conceived and designed the experiments: SM. Performed the experiments: YM NN. Analyzed the data: SM HH. Contributed reagents/materials/analysis tools: SM KS. Wrote the manuscript: SM SK.","KS and SM have received grants and lecture honoraria from Daiichi-Sanlyo Co. Ltd., MSD, Dainippon Sumitomo Pharma Co. Ltd., Takeda Pharma Co. Ltd., Novartis Pharma, Boehringer Ingelheim and Astellas Pharma Inc. KS is a Chief Director and SM is a Director of NPO Clinical and Applied Science, Fukuoka, Japan. KS has Endowed Departments of “Department of Molecular Cardiovascular Therapeutics” supported by MSD, Co. LTD. SM belongs to Department of Molecular Cardiovascular Therapeutics supported by MSD, Co. LTD. KS and SM were funded by Daiichi Sankyo Co. Ltd. NN and HH are employed by Daiichi Sankyo Co. Ltd. Co-author SK is a PLOS ONE Editorial Board member. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","11","Shin-Ichiro Miura","SIM",6,TRUE,1,2,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
